These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 947327)

  • 21. [In vitro antibacterial effect of sulfamoxole/trimethoprim and sulfamethoxazole/trimethoprim].
    Hingst V; Sonntag HG
    Med Welt; 1979 Aug; 30(33):1199-201. PubMed ID: 491915
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lung tissue diffusion of intravenous trimethoprim-sulfamethoxazole combination (author's transl)].
    Morel C; Langeard M; Vergnaud M; Monrocq N
    Pathol Biol (Paris); 1982 Jun; 30(6):380-4. PubMed ID: 7050846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
    Bismuth R; Jarlier V; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of cefoxitin compared with the activity of other antibiotics and trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    Med Klin; 1978 Mar; 73(12):423-7. PubMed ID: 347234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123). 2. Results of a multicenter clinical trial of CN 3123 in infections of the kidneys and urinary tract].
    Eckstein E; Etzel M; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):665-70. PubMed ID: 947328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 27. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibacterial effect of sulfanilamide combination drugs].
    Metz H; Preac-Mursic V
    Med Klin; 1972 Dec; 67(49):1626-31. PubMed ID: 4566636
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on synergistic behaviour and pharmacokinetics of the combination sulfonamide/trimethoprim. IV. A comparative study on potentiating the trimethoprim effect by various sulfonamides and critical observations on its dosing (author's transl)].
    Seydel JK; Wempe E
    Arzneimittelforschung; 1977; 27(8):1521-32. PubMed ID: 334187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial action of septrin in vitro against microorganisms causing urinary tract infections in comparison with their sensitivity to other chemotherapeutic and antibiotic drugs].
    Ganczarski A; Augustyniak G; Brauner G; Prelich A; Stapor K
    Przegl Lek; 1973; 30(3):303-7. PubMed ID: 4633373
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR
    Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract]   [Full Text] [Related]  

  • 34. [The sulfamethoxazole-trimethoprim combination 1st survey into its in vitro activity in brazzaville, Congo Results of 780 bacterial strains isolated at the National Laboratory and the General Hospital in a single year].
    Yala F
    Bull Soc Pathol Exot Filiales; 1979; 72(3):198-204. PubMed ID: 400121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibacterial therapy of urinary tract infections. Results of a clinical trial with the combination sulfamoxol/Trimethoprim (= CN 3123) (author's transl)].
    Peters HJ; Nuri M; Popa G
    MMW Munch Med Wochenschr; 1977 Mar; 119(12):409-12. PubMed ID: 404528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.
    Kuipers JS
    Chemotherapy; 1979; 25(2):77-82. PubMed ID: 446188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the in vitro antibacterial activity of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole combinations].
    Thabaut A
    Therapie; 1983; 38(4):399-404. PubMed ID: 6606237
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacteriostatic and bactericidal activity of two trimethoprim-sulfonamide combinations.
    Böhni E
    Chemotherapy; 1976; 22(3-4):262-73. PubMed ID: 1269292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New bacteriological results with Co-trimoxazole (author's transl)].
    Böhni E
    Wien Klin Wochenschr; 1979 Oct; 91(19):664-71. PubMed ID: 538931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents.
    Rohrich PJ; Ling GV; Ruby AL; Jang SS; Johnson DL
    J Am Vet Med Assoc; 1983 Oct; 183(8):863-7. PubMed ID: 6415021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.